Durvalumab and Lurbinectedin for the Treatment of Relapsed or Refractory Small Cell Lung Cancer

Name: Durvalumab and Lurbinectedin for the Treatment of Relapsed or Refractory Small Cell Lung Cancer
License: Public Domain

Mayo Clinic

ClinicalTrials.gov · Datasets · License: Public Domain

Open Source ↗

platinum

platinum-resistant lung small cell carcinoma, platinum-sensitive lung small cell carcinoma, recurrent extensive stage lung small cell carcinoma, refractory extensive stage lung small cell carcinoma

This document is indexed with metadata only — full text is not available in the archive for this record. Open the official source ↗

Record · ID 208427
Retrieved via Conceptio — every document is proof-bundled with source, license, and retrieval metadata.